GlaxoSmithKline Searching For Hit Drugs Pours $95M Into DNA Dark Matter
Jul 8, 2015, 00:00 AM
by
Michael Croft
Forbes | GlaxoSmithKline is investing $95 million
in a nonprofit research center in Seattle called the Altius
Institute for Biomedical Sciences, focusing on the "dark matter" of
the genome.
July 08, 2015 | GlaxoSmithKline is investing $95 million in a nonprofit research center in Seattle called the Altius Institute for Biomedical Sciences, focusing on the "dark matter" of the genome. Forbes